Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B17 | O75795 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2044938 | 0.81 | UGT2B17 (0.49) | UGT2B17 | |
| SCHEMBL15821768 | 0.76 | SLC9A3 (0.30) | HTR2AHTR2CHTR2B | |
| SCHEMBL20634836 | 0.76 | SLC9A3 (0.30) | HTR2AHTR2CHTR2B | |
| SCHEMBL29392659 | 0.76 | SLC9A3 (0.30) | HTR2AHTR2CHTR2B | |
| SCHEMBL21451141 | 0.76 | SLC9A3 (0.30) | HTR2AHTR2CHTR2B | |
| SCHEMBL22246617 | 0.72 | HTR2A (0.33) | UGT2B17HTR2AHTR2CHTR2B | |
| SCHEMBL17278091 | 0.67 | HTR2C (0.44) | UGT2B17HTR2AHTR2CHTR2BNOTUM | |
| SCHEMBL3664467 | 0.67 | — | — | |
| SCHEMBL14784874 | 0.66 | HCAR2 (0.34) | HTR2AHTR2C | |
| SCHEMBL19827774 | 0.64 | HTR2A (0.35) | HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981801-B2 | Polypropylene composition | BOREALIS AG (AT) | 2024-05-14 | — | — | US | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| CN-110770264-B | Process for preparing heterophasic propylene copolymers | 博里利斯股份公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-110177798-B | Catalyst and process for preparing same | 博里利斯股份公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| CN-110741039-B | Polypropylene composition | 博里利斯股份公司 | 2022-02-18 | — | — | CN | disclosed |
| US-11078304-B2 | Process for preparing heterophasic propylene copolymers | BOREALIS AG (AT) | 2021-08-03 | — | — | US | disclosed |
| EP-3541823-B1 | CATALYSTS | BOREALIS AG (AT) | 2020-12-30 | — | — | EP | disclosed |
| EP-3652247-A1 | POLYPROPYLENE COMPOSITION | Borealis AG (AT) | 2020-05-20 | — | — | EP | disclosed |
| EP-3649162-A1 | PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | Borealis AG (AT) | 2020-05-13 | — | — | EP | disclosed |
| EP-3541823-A1 | CATALYSTS | Borealis AG (AT) | 2019-09-25 | — | — | EP | disclosed |
| WO-2019012110-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2019-01-17 | — | — | WO | disclosed |
| WO-2019007655-A1 | PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | BOREALIS AG (AT) | 2019-01-10 | — | — | WO | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
| EP-3301098-A1 | PROCESS FOR THE PREPARATION OF A LIGAND FOR A CATALYST | Borealis AG (AT) | 2018-04-04 | — | — | EP | disclosed |
| EP-2935296-B1 | CATALYST | BOREALIS AG (AT) | 2017-11-15 | — | — | EP | disclosed |
| US-20150329653-A1 | CATALYST | BOREALIS AG (AT) | 2015-11-19 | — | — | US | disclosed |
| EP-2935296-A1 | CATALYST | Borealis AG (AT) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014096282-A1 | CATALYST | BOREALIS AG (AT) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | UGT2B17 3744/4885HTR2A 1980/4885HTR2C 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.